Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05863507 · ClinicalTrials.gov registry record · NA
The Influence of Daily Grapes Intake on Sarcopenia in Postmenopausal Women
A NA study of Sarcopenia, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT05863507: Completed NA study of Sarcopenia, sponsored by University of California, Davis.
NCT05863507 is a NA study of Sarcopenia that has completed, run by University of California, Davis. The registered enrollment target is 15 participants, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05863507, a NA study of Sarcopenia, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Sarcopenia, characterized by loss of muscle mass and function, is a prevalent disorder in elderly individuals or individuals with chronic diseases. Given the above, there is an ongoing intensive search for novel therapies, including dietary ones, that can attenuate the loss of muscle mass and strength in the elderly. A proposed mechanism by which skeletal muscles might mediate their protective effect against sarcopenia is by secreting myokines as irisin. Phenolic compounds presents in grape have shown to be able to induce irisin secretion in muscle from rats supplemented with a grape pomace extract. The Ian of this study is to evaluate this mechanism in humans.
Primary Outcome
The investigators will measure irisin levels in plasma
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Grape powder supplementation
Study Locations (1)
California
- Nutrition Department, Ragle Facility University of California, Davis - Davis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2023-04-01 |
| Est. Completion | 2024-07-14 |
| Phase | NA |
What the finished NCT05863507 record still lists
NCT05863507 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 80-participant average among 41 other Sarcopenia trials with a reported enrollment target (81% lower).
The record links to 1 condition, with Sarcopenia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT05863507 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05863507 about?
NCT05863507 is a clinical study titled "The Influence of Daily Grapes Intake on Sarcopenia in Postmenopausal Women". Sarcopenia, characterized by loss of muscle mass and function, is a prevalent disorder in elderly individuals or individuals with chronic diseases. Given the above, there is an ongoing intensive search for novel therapies, including dietary ones, that can attenuate the loss of muscle mass and streng...
What is the current status of trial NCT05863507?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2023-04-01. Estimated completion is 2024-07-14.
What conditions does trial NCT05863507 study?
This clinical trial studies the following conditions: Sarcopenia.
What interventions are being tested in trial NCT05863507?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Grape powder supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05863507?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05863507 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcopenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05863507's enrollment target sits among peer trials
15 38th of 41 higher than 4 of 41 other Sarcopenia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sarcopenia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Exercise and Nutritional Prehabilitation for Head and Neck Cancer Patients
RECRUITING · NA
-
Effects of Whole-body Electrical Muscle Stimulation Exercise on Spinal Motoneuronal Activation in Older Adults
RECRUITING · NA
-
Strength Training and Resveratrol
RECRUITING · NA
-
Project Gnosis: the Neurophysical and Psychosocial Health Outcomes of Tai Chi for Older Adults with Cognitive Concerns or Mild Cognitive Impairment
RECRUITING · NA
-
Multidimensional Predictive Modeling to Understand Mechanisms of Exercise Response Heterogeneity in Older Adults (M3AX)
RECRUITING · NA
-
C-Protein in Fatigue and Aging
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI